Additionally, Huang et al. [6] and Todd et al. [41], using the NHANES 2001–2008 cycles, reported that higher levels of the metabolites MBzP, MnBP, MiBP, MCPP, and ∑DEHP were associated with both an increased odds [41] and increased risk [6] of diabetes, with differences in the strength of the dose–response relationships by race/ethnicity [6]. The gene discussed is NMRK2; the disease is diabetes mellitus.